Advent Access has secured S$2.6m ($1.92m) in a pre-series A venture financing round led by Accuron MedTech.
The Singapore-based company plans to use the funds to progress the development of its av-Guardian technology, which provides vascular access to dialysis patients.
Linear Health Sciences LLC has secured additional funding of $1.54m in a series A venture financing round, bringing the total funds raised to $3m.
The company previously raised $1.2m from i2E, SeedStep Angels Group, and other investors.
The US-based safety technology solutions firm plans to use the proceeds for developing orchid safety release valve (SRV).
US-based medical devices developer Virtual Incision Corporation has secured $18m in a series B financing round led by Bluestem Capital Company LLC and Sinopharm Capital Management Co Ltd.
Virtual Incision plans to use the proceeds to submit a pre-market notification to the US Food and Drug Administration (FDA) for its miniaturised robotically assisted surgical device (RASD).
Skyline Medical Inc plans to raise $2.29m through a public offering of 1,857,179 shares of its common stock priced at $1.24 a share.
Esousa holdings LLC will issue the shares as the selling stockholder from time to time.
Brazilian diagnostic services provider Fleury SA has raised $92m through a public offering of notes.
Banco Itau BBA SA served as the underwriter for the offering.
Orthocell Ltd has raised A$1.5m ($1.13m) through the private placement of 4,411,765 shares priced at A$0.34 ($0.25) each.
The regenerative medicine company plans to use the funds towards research activities and for the commercialisation of its pipeline products, including CelGro and Ortho – ATI.
